Literature DB >> 20230207

Annexin V binding to platelets is agonist, time and temperature dependent.

Sofia Ramstrom1, Sarah O'Neill, Eimear Dunne, Dermot Kenny.   

Abstract

Platelets bind annexin V when stimulated with combinations of platelet agonists such as collagen and thrombin. Previous studies have demonstrated significant heterogeneity of platelets binding annexin V. The relative role of the thrombin protease-activated receptors (PARs), PAR1 and PAR4, together with different methods of platelet preparation on annexin V binding to platelets is unclear. We therefore investigated the role of PAR1- and PAR4-activating peptides in combination with collagen-related peptide on annexin V binding. In diluted whole blood, PAR1- and PAR4-activating peptides were as effective as thrombin in inducing annexin V binding. However, in washed platelets, PAR-activating peptides were less potent than thrombin at inducing annexin V binding. This difference was more pronounced when experiments were performed at 37 degrees C compared to room temperature. In studies of diluted whole blood, platelet rich plasma and washed platelets, platelets incubated at room temperature bound more annexin V than platelets incubated at 37 degrees C. We also saw a significant effect of time on annexin V binding, in that more annexin V bound to platelets with longer incubation times. In conclusion, PAR1 and PAR4-activating peptides were as effective as thrombin in inducing annexin V binding in combination with collagen-related peptide in diluted whole blood and platelet rich plasma, but not in washed platelets. In addition, incubation temperature and time has a strong influence on annexin V binding to platelets. Thus variations in these conditions may explain the differences observed between previous studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20230207     DOI: 10.3109/09537101003660564

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  6 in total

1.  The apoptotic actions of platelets in acute ischemic stroke.

Authors:  Ozge Cevik; Zelal Adiguzel; Ahmet Tarik Baykal; Goksel Somay; Azize Sener
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 2.  Clinical imaging of vascular disease in chronic kidney disease.

Authors:  Alan A Sag; Adrian Covic; Gerard London; Marc Vervloet; David Goldsmith; Jose Luis Gorriz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2016-02-22       Impact factor: 2.370

3.  Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulation.

Authors:  Stephen R Clark; Christopher P Thomas; Victoria J Hammond; Maceler Aldrovandi; Gavin W Wilkinson; Keith W Hart; Robert C Murphy; Peter W Collins; Valerie B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

4.  Topological Adaptation of Transmembrane Domains to the Force-Modulated Lipid Bilayer Is a Basis of Sensing Mechanical Force.

Authors:  Jiyoon Kim; Joonha Lee; Jiyoung Jang; Feng Ye; Soon Jun Hong; Brian G Petrich; Tobias S Ulmer; Chungho Kim
Journal:  Curr Biol       Date:  2020-03-12       Impact factor: 10.900

5.  Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol.

Authors:  Anna Linnea Södergren; Sofia Ramström
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

6.  Varying effects of tyrosine kinase inhibitors on platelet function-A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications?

Authors:  Suryyani Deb; Niklas Boknäs; Clara Sjöström; Anjana Tharmakulanathan; Kourosh Lotfi; Sofia Ramström
Journal:  Cancer Med       Date:  2019-11-12       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.